All together our data show a significant increase in the expression of NeuN, GAP43 and SYP genes, in the hippocampal cell cultures that were exposed to Aβ and treated with AGS, suggesting that in the in vitro AD model, the increase in their expression is part of the neuroprotective mechanism of the telomerase increasing compound. The gene discussed is GAP43; the disease is Alzheimer disease.